门冬胰岛素联合阿卡波糖治疗2型糖尿病疗效观察  

Insulin aspart joint acarbose oral medications clinical observation on effect of type 2 diabetes

作　　者：章春花[1] Zhang Chun-hua(Suzhou Industrial Park, Xinghai Hospital, Jiangsu 215100China)

机构地区：[1]江苏苏州工业园区星海医院,215000

出　　处：《实用糖尿病杂志》2017年第3期25-26,共2页Journal of Practical Diabetology

摘　　要：随机选择2010年1月~2016年8月口服降糖效果不佳的T2DM80例,观察组40例给予门冬胰岛素联合阿卡波糖治疗,其余选用常规治疗办法。结果:降糖效果提升10%~20%左右,随访调查1~3个月,降糖效果稳定,2例存在不良问题。结论:2型糖尿病如果口服降糖效果不佳,需斟酌更换用药。Objective To study the Insulin aspart joint acarbose oral hypoglycemic effect of poor curative effect in patients with type 2 diabetes. Methods Randomly selected in January 2010 - August 2016 poor oral hypoglycemic effect of 80 patients with type 2 diabetes, the observation group 40 cases give Insulin aspart with acarbose therapy, the rest of the choose regular treatment, using the feedback information in the medical record data, and effect observation. Results The hypoglycemic effect of 10% -20% , 1 -3 months follow-up survey ,hypoglycemic effect is stable ,2 cases of bad problems. Conclusion Type 2 diabetes if poor oral hypoglycemic effect, to consider replacement drugs, choose the combination way, can effectively solve the problem.

关 键 词：门冬胰岛素 阿卡波糖 降糖药 2型糖尿病 

分 类 号：R587.1[医药卫生—内分泌]